Korea Asset Investment Securities Co., Ltd. (KOSDAQ:190650)
6,880.00
+20.00 (0.29%)
At close: Aug 18, 2026
KOSDAQ:190650 Revenue
In the fiscal year ending March 31, 2026, Korea Asset Investment Securities had annual revenue of 245.07B KRW with 6.09% growth. Korea Asset Investment Securities had revenue of 62.99B in the quarter ending March 31, 2026, with 56.19% growth.
Revenue
245.07B
Revenue Growth
+6.09%
P/S Ratio
0.18
Revenue / Employee
n/a
Employees
n/a
Market Cap
43.95B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 245.07B | 14.06B | 6.09% |
| Mar 31, 2025 | 231.01B | 28.84B | 14.27% |
| Mar 31, 2024 | 202.17B | -8.75B | -4.15% |
| Mar 31, 2023 | 210.92B | 3.38B | 1.63% |
| Mar 31, 2022 | 207.54B | 53.09B | 34.37% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Samchuly Bicycle | 170.73B |
| Orient Precision Industries | 153.23B |
| Genoray | 108.27B |
| HLB bioStep | 73.96B |
| The Asia Business Daily | 73.03B |
| Actoz Soft | 66.56B |
| Green Lifescience | 51.02B |
| Obigo | 40.36B |